MSF
MSF at the IAC
Doctors Without Borders Home

« MSF-USA home page

MSF at the IAC

Poster Presentations

Monday, August 4 | Hall D

  • Discordant responses to antiretroviral treatment: prevalence, risk factors and associated mortality in Rwanda [MOPE0048] Poster Abstract
  • Good immune restitution but unsatisfactory viral suppression in children on ART in remote Western Kenyan area [MOPE0213] Poster Abstract
  • HIV/AIDS survival in adults and children under HAART in rural Malawi [MOPE0059] Poster Abstract
  • Increased baseline body weight is a risk factor associated with virological failure while on antiretroviral treatment [MOPE0049] Poster Abstract
  • Quality-of-care indicators for international HIV/AIDS care: scaling up beyond the numbers [MOPE0039] Poster Abstract
  • "Fear of stigma is stronger than fear of death":

    a workplace initiative to reduce sickness and death due to HIV/AIDS among health staff in Malawi

  • Immuno-virological and toxicity outcomes of HIV infected patients after 48 months of ART in Phnom Penh, Cambodia [MOPE0043] Poster Abstract

Tuesday, August 5 | Hall D

  • Low level of virological failure and drug resistance among patients receiving antiretroviral treatment under programme conditions in Maputo, Mozambique [TUPE0353] Abstract

Wednesday, August 6 | Hall D

  • Drug resistance degree is associated with duration of ARV exposure and predicted by baseline CD4 and gender in HIV-infected patients failing first-line WHO-recommended ARV regimen: a cross-sectional viral load survey of a cohort in Cameroon [WEPE0034] Poster Abstract
  • Nurses and medical assistants taking charge:

    task-shifting HIV care and HAART initiation in resource-constrained and rural Malawi

  • "Fear of stigma is stronger than fear of death": a workplace initiative to reduce sickness and death due to HIV/AIDS among health staff in Malawi [WEPE1019] Abstract See video to the right
  • Nurses and medical assistants taking charge: task-shifting HIV care and HAART initiation in resource-constrained and rural Malawi [WEPE0106] Poster Abstract See video to the right

Thursday, August 7 | Hall D

  • Analysis of clinical, immunological outcomes of pediatric cohort of patients treated in Bulawayo, Zimbabwe [LBPE1155] Poster Abstract
  • Early mortality (pre and post antiretroviral treatment) amongst children with HIV/AIDS enrolled in two programmes in Cambodia [THPE0101] Abstract
  • Evaluation of a systematic substitution of zidovudine for stavudine-based HAART in a programme setting in rural Cambodia [THPE0196] Abstract
  • Risk factors for hepatotoxicity of nevirapine-containing antiretroviral drug regimens in a large antiretroviral treatment programme in Rwanda [THPE0179] Poster Abstract
  • Toxicity of stavudine- and nevirapine-containing antiretroviral treatment regimens: Incidence and risk factors after three years in a large cohort in Rwanda [THPE0188] Poster Abstract
  • Weight evolution in patients after stavudine substitution for lipoatrophy in Rwanda: comparison of zidovudine with tenofovir/abacavir [THPE0149] Poster Abstract

Download all abstracts: